ATS 2024 Final Program

Click on the session title to view the speakers

314

WEDNESDAY • MAY 22

multidisciplinary clinicians (nurses, social workers, etc.), and public health professionals. Objectives At the conclusion of this session, the participant will be able to: • identify indoor and adjacent outdoor school air pollutants and understand the associated risks to childhood respiratory health on both an individual and population level • describe the latest recommendations and findings regarding the regulatory oversight of school air quality and the engineering of school ventilation systems • describe evidence-based advocacy interventions necessary to limit exposure to school-based environmental health pollutants in the US and abroad, thereby improving quality of life and outcomes for children with respiratory disease Children spend many hours in school and are susceptible to respiratory effects of poor classroom air quality from indoor materials, pathogens, and pollution. However, there are no federal recommendations on school indoor air. This session will feature experts in indoor air quality who will discuss the effects of classroom exposures on respiratory health, the omics of these effects, the science of indoor air ventilation from an engineering perspective, and strategies to partner with neighborhood organizations to improve indoor air. Attendees will be equipped to advocate for improved school indoor air quality to improve pediatric respiratory health and academic inequities. 8:15 Why the Lack of Federal Regulation on School Indoor Air Quality Should Concern Clinicians and Scientists 8:20 School Classroom Ventilation: Where Engineering Intersects with Medicine 8:37 Ventilation matters: Respiratory effects of aerosolized virus in classrooms and daycare centers 8:54 The Respiratory Effects of Particulate Matter in School Indoor Air 9:11 The Impact of School-Associated Traffic-Related Air Pollution on Classrooms 9:28 Improving School Indoor Air Through School Community Partnerships

BASIC • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM

D8 GLOBAL PERSPECTIVES OF PULMONARY HYPERTENSION

BIOLOGY AND MANAGEMENT? AN ATS/ERS JOINT SYMPOSIUM

Assemblies on Pulmonary Circulation, European Respiratory Society 8:15 a.m. - 9:45 a.m.

Marriott Marquis San Diego Marina Grand Ballroom 5-6 (Lobby Level, North Tower)

Target Audience Physicians, researchers and nurses from all fields interested in learning about state-of-the-art translational research and pulmonary vascular disease management from a global

perspective. Objectives

At the conclusion of this session, the participant will be able to: • facilitate discussion from a global health perspective on new translational findings with the goal to enable the development of effective treatment for PH and PVD. • engage in discussions about the global perspective on clinical trial design/achievements and disease management for development of novel therapeutics for PH and PVD. • identify and discuss approaches that can be leveraged to push the pulmonary vascular field forward at the translational research and clinical trial levels with the goal to improve patient outcomes. A collaborative session between the American Thoracic Society and European Respiratory Society, this symposium partners talks from global perspectives and highlights key scientific insights and technologies that are used to understand disease and cellular heterogeneity, the current biomarker landscape for early diagnosis and disease management in pulmonary hypertension (PH) and pulmonary vascular disease (PVD), and the current clinical trial landscape in North America and Europe. 8:15 Complex Disease in Context: Bioengineering Approaches to Study Cell-Specific Processes in PH and PVD 8:30 Complex Disease in Context: Leveraging Large Datasets to Understand Cellular Heterogeneity in PH and PVD

ATS 2024 • San Diego, CA